NYSE:CORHealthcare
Will Cencora’s (COR) Revenue Miss and Probes Change Its Margin-Expansion Narrative?
Cencora’s recent past events include fiscal Q2 2026 results showing higher sales of about US$78.36 billion and net income of roughly US$1.64 billion year over year, alongside confirmed 2026 revenue growth guidance of 4% to 6% and a quarterly cash dividend of US$0.60 per share.
Despite year-on-year earnings growth and plans to resume share repurchases later in the fiscal year, the quarter’s revenue miss, lowered revenue outlook, and subsequent securities-law investigations by multiple law...